BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33277234)

  • 1. Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic.
    de Val J; Sohal G; Sarwar A; Ahmed H; Singh I; Coleman JJ
    Eur J Hosp Pharm; 2021 Jan; 28(1):10-15. PubMed ID: 33277234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of field hospital pharmacy services during the COVID-19 pandemic.
    Wallis N; Gust C; Porter E; Gilchrist N; Amaral A
    Am J Health Syst Pharm; 2020 Sep; 77(19):1547-1551. PubMed ID: 32539128
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacist facing the logistics of safely dispensing, storing and preserving drugs in healthcare units.
    Cabañas MJ; Queralt Gorgas M
    Farm Hosp; 2020 Jun; 44(7):53-56. PubMed ID: 32533672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy.
    Aston J; Singh I; Cheng C; Considine A
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e36-e40. PubMed ID: 33853853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.
    García-Gil M; Velayos-Amo C
    Farm Hosp; 2020 Jun; 44(7):32-35. PubMed ID: 32533667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK.
    Barnett NL
    Br J Clin Pharmacol; 2019 Aug; 85(8):1666-1669. PubMed ID: 30986325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical care pharmacy workforce: a 2020 re-evaluation of the UK deployment and characteristics.
    Borthwick M; Barton G; Ioannides CP; Forrest R; Graham-Clarke E; Hanks F; James C; Kean D; Sapsford D; Timmins A; Tomlin M; Warburton J; Bourne RS
    Hum Resour Health; 2023 Mar; 21(1):28. PubMed ID: 37004069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for development of pharmacy support models for COVID-19 alternate care sites.
    Nelsen G; Pigott H; Hopkinson C; Formea CM
    Am J Health Syst Pharm; 2020 Sep; 77(19):1592-1597. PubMed ID: 34279583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases.
    Bazzell B; Wagner D; Durant KM; Callahan B
    Am J Health Syst Pharm; 2020 Oct; 77(21):1763-1770. PubMed ID: 32705115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
    Pulk RA; Leber M; Tran L; Ammar M; Amin N; Miller L; Yazdi M
    Am J Health Syst Pharm; 2020 Oct; 77(22):1874-1884. PubMed ID: 32710774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring example models of cross-sector, sessional employment of pharmacists to improve medication management and pharmacy support in rural hospitals.
    Tan AC; Emmerton LM; Hattingh L; La Caze A
    Rural Remote Health; 2015; 15(4):3441. PubMed ID: 26613289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic.
    Cheng C; Walsh A; Jones S; Matthews S; Weerasooriya D; Fernandes RJ; McKenzie CA
    Int J Clin Pharm; 2023 Apr; 45(2):293-303. PubMed ID: 36367601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing pharmacy services in a basketball arena: Reflections on building a pharmacy in a COVID-19 surge facility.
    Warr D; Storey E; Denys M; Brown S; Rose C
    Am J Health Syst Pharm; 2021 Feb; 78(5):416-425. PubMed ID: 33386406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 pandemic preparedness: A practical guide from clinical pharmacists' perspective.
    Ahuja T; Merchan C; Arnouk S; Cirrone F; Dabestani A; Papadopoulos J
    Am J Health Syst Pharm; 2020 Sep; 77(18):1510-1515. PubMed ID: 34279575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital pharmacist experience in a multidisciplinary team in special care settings.
    Santolaya-Perrin R; García-Martín Á; Carrero-Fernández A; Torres-Santos-Olmo R
    Farm Hosp; 2020 Jun; 44(7):36-39. PubMed ID: 32533668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining comprehensive pharmacy services during a pandemic: Recommendations from a designated COVID-19 facility.
    Sin JH; Richards II; Ribisi MS
    Am J Health Syst Pharm; 2020 Sep; 77(18):1522-1528. PubMed ID: 32533829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of hospital drug policy in the UK.
    Cotter SM; McKee M
    J Health Serv Res Policy; 1997 Jul; 2(3):144-53. PubMed ID: 10180375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.